Efficacy of a recombinant antithrombin preparation for the treatment of intra-abdominal infectious DIC

Efficacy of a recombinant antithrombin preparation for the treatment of intra-abdominal infectious DIC - Efficacy of a recombinant antithrombin preparation for the treatment of intra-abdominal infectious DIC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043745

Enrollment

200

Registered

2021-04-02

Start date

2021-04-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic DIC

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 18 years or older diagnosed with septic DIC caused by intra-abdominal infection treated in the Intensive Care Unit of our hospital between April 1, 2014 and July 31, 2020.

Exclusion criteria

Exclusion criteria: Pregnant women, patients with end-stage cancer, patients with cirrhosis, patients who do not meet the diagnostic criteria for acute DIC

Design outcomes

Primary

Measure	Time frame
Difference in DIC improvement rate within 7 days of onset	—

Secondary

Measure	Time frame
Physiological severity and organ damage, AT activity level, 28-day mortality	—

Countries

Japan

Contacts

Public Contactyoshinori tanigawa

Saga University Hospital Anesthesiology and Critical Care Medicins

e6580@cc.saga-u.ac.jp+81952343370

Outcome results